Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-030902
Filing Date
2022-03-07
Accepted
2022-03-07 09:00:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm228448d1_424b5.htm 424B5 378382
2 GRAPHIC tm228448d1_424b5-img001.jpg GRAPHIC 7138
3 GRAPHIC tm228448d1_424b5-img002.jpg GRAPHIC 7138
4 GRAPHIC tm2135048d1_s3sp1img001.jpg GRAPHIC 39042
  Complete submission text file 0001104659-22-030902.txt   453296
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261638 | Film No.: 22716447
SIC: 2834 Pharmaceutical Preparations